Concepedia

J Sloan-Lancaster

JS

Statistics

Publications

8

Citations

1.1K

H-Index

8

Active since

1993

Affiliations

Washington University in St. Louis(Current)

Eli Lilly (United States)

Stanford University

J Sloan-Lancaster is an author at Washington University in St. Louis specializing in life sciences, signal transduction, and immunology.

Publications per year

1993–2013

8

Publications

8

LY2439821, a humanized anti–interleukin‐17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double‐blind, placebo‐controlled, proof‐of‐concept study

Mark C. Genovese, Filip Van den Bosch, Stephanie Roberson et al. · Arthritis & Rheumatism · 2010 · 451 citations

, , +17

Th2 cell clonal anergy as a consequence of partial activation.

J Sloan-Lancaster, Brian D. Evavold, Paul M. Allen · The Journal of Experimental Medicine · 1994 · 169 citations · Full text

, , +17

Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides

Brian D. Evavold, J Sloan-Lancaster, Benjamin Hsu et al. · The Journal of Immunology · 1993 · 166 citations

, , +16

Selective loss of the calcium ion signaling pathway in T cells maturing toward a T helper 2 phenotype

J Sloan-Lancaster, T H Steinberg, Paul M. Allen · The Journal of Immunology · 1997 · 86 citations

, , +17

Selective activation of the calcium signaling pathway by altered peptide ligands.

J Sloan-Lancaster, T H Steinberg, Paul M. Allen · The Journal of Experimental Medicine · 1996 · 79 citations · Full text

, , +17

1–5 of 8